StockData
COSCIENS Biopharma Inc. logo

COSCIENS Biopharma Inc. (CSCIF) stock

CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 20-F on Mar 25, 2026Score 1/30
$6.49+0.00 (0.00%)

Close on Oct 19, 2026Market cap $24.10MP/E –Yield –

COSCIENS Biopharma EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was -$3.27. The highest annual figure on record is $6.00 in fiscal 2018.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$3.27–
FY2024Dec 31, 2024-$5.93–
FY2023Dec 31, 2023-$1.89-201.6%
FY2022Dec 31, 2022$1.86–
FY2021Dec 31, 2021-$1.82–
FY2020Dec 31, 2020-$3.11–
FY2019Dec 31, 2019-$8.75-245.8%
FY2018Dec 31, 2018$6.00–
FY2017Dec 31, 2017-$28.00–
FY2016Dec 31, 2016-$60.25–
FY2015Dec 31, 2015-$453500.00–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026$2.90–
Q3 FY2025Sep 30, 2025-$0.57–
Q2 FY2025Jun 30, 2025-$0.85–
Q1 FY2025Mar 31, 2025-$1.16–
Q3 FY2024Sep 30, 2024-$1.85–
Q2 FY2024Jun 30, 2024-$0.64–
Q1 FY2024Mar 31, 2024-$0.76–
Q3 FY2023Sep 30, 2023-$0.42–
Q2 FY2023Jun 30, 2023-$0.47–
Q1 FY2023Mar 31, 2023-$3.51-977.5%
Q3 FY2022Sep 30, 2022-$0.70–
Q2 FY2022Jun 30, 2022-$0.87–
Q1 FY2022Mar 31, 2022-$0.50–
Q3 FY2021Sep 30, 2021$0.40–
Q2 FY2021Jun 30, 2021-$0.43-143.0%
Q1 FY2021Mar 31, 2021-$0.50–
Q3 FY2020Sep 30, 2020-$0.50-300.0%
Q2 FY2020Jun 30, 2020-$3.75–
Q1 FY2020Mar 31, 2020$1.00–
Q3 FY2019Sep 30, 2019-$0.50–
Q2 FY2019Jun 30, 2019$0.25–
Q1 FY2019Mar 31, 2019-$7.50–
Q3 FY2018Sep 30, 2018-$3.75–
Q2 FY2018Jun 30, 2018-$4.00–

More COSCIENS Biopharma figures

See a number that looks wrong?